IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Tempest Therapeutics Inc (OVASUSD)

Q1 2026 vs Q2 2026

Comparing institutional holders between quarters

Quarters

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile
Versant Venture Management, LLC
UNCHANGED
Shares269,772 from 269,772
Change0 (0%)
Value$299.4K (-$143.0K)
Filed 2026-08-12
Status
Versant Venture Management, LLC
UNCHANGED269,772269,77200%$442.4K$299.4K-$143.0K2026-08-12
Showing 1 of 1 institutions